17 Aug 2011 16:19

e-Therapeutics plc ("e-Therapeutics" or the "Company")
Â
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Â
e-Therapeutics (AIM: ETX), the drug discovery and development company, announces the following Director's Market Share Purchase.
Â
On 16 August 2011 Steve Self, Executive Director, purchased 56,600 ordinary shares at 35p per share. His resultant total holding is 253,577 shares, representing 0.18% of the issued share capital of the Company, which currently stands at 138,126,467 shares all carrying voting rights.
Â
17 August 2011.
Â
For more information, please contact:
Â
e-Therapeutics plc
Malcolm Young
Tel: +44 (0) 191 233 1317
E-mail: malcolm@etherapeutics.co.uk
www.etherapeutics.co.uk
Â
Panmure Gordon (UK) Limited
Andrew Burnett / Aubrey Powell
Tel: +44 (0) 20 7459 3600
www.panmure.com
Â
Â
Â